GABAPETNIN,BENZOCAINE,PREGABALIN,TRANEXAMIC ACID,LEVOCARNITINE, Zhejiang Bamboo Pharmaceuticals Co., Ltd. --API MANUFACTURER

Company News

2026

05-23

[Company News]Tranexamic acid has obtained the CEP certificate, NO.: CEP 2025-258 - Rev 00

Detail >
2026

04-23

[Company News]April 23, 2026: Warmly celebrate that Bamboo Pharmaceuticals' product based on Pregabalin has obtained the New CEP certificate, NO.: CEP 2025-610 - Rev 00

Detail >
2026

04-09

[Company News]Warmly celebrate that Bamboo Pharmaceuticals' product based on Levocarnitine has obtained the CEP certificate

Detail >
2026

04-08

[Company News]Warmly celebrate that Bamboo Pharmaceuticals' product based on Etodolac has obtained the CEP certificate

Detail >
2024

12-30

[Company News]Congratulations to our company received US FDA approval letter on Dec.11,2024, which is the first inspection approval for our products

Detail >
2022

10-10

[Company News]first written confirmation

Detail >
2022

10-10

[Company News]zhejiang bamboo pharmaceuticals got manufacturing license

Detail >
2022

02-15

[Company News]start production at Feb.,2022

Detail >

19 Records Next 12 3

Company Profile

News

Products

Links

Sales department contact information:

Manufacturing address:
No. 9, Weiyi Road, Hangzhou Bay Economic and Technological Development Zone, Shangyu District, Shaoxing City, Zhejiang Province,China
Tel: +86-13588080268
Email：bamboopharma@163.com,sales@bamboopharma.com
Sales office address:No.288,shixin south Road,xiaoshan,Hangzhou,Zhejiang

Copyright(C)2020, Zhejiang Bamboo Pharmaceuticals Co., Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle

Mobile version